WO2025215617 - A HERBAL TEA WITH BENEFICIAL EFFECTS ON T2DM PATIENTS
National phase entry is expected:
Publication Number
WO/2025/215617
Publication Date
16.10.2025
International Application No.
PCT/IB2025/053864
International Filing Date
14.04.2025
Title **
[English]
A HERBAL TEA WITH BENEFICIAL EFFECTS ON T2DM PATIENTS
[French]
TISANE PRÉSENTANT DES EFFETS BÉNÉFIQUES SUR DES PATIENTS ATTEINTS DE T2DM
Applicants **
KARTHIGESU, Kulanayagam
Inventors
SIVAPALAN, Sivansuthan
RAJENDRA, Surenthirakumaran
SUNIL NAVARATNARAJA, Thiyahiny
KESAVAN, Vithegi
PREMAKUMARA, Sirimal
Priority Data
LK/P/1/23510
07.04.2024
LK
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP Australia
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Natural Person
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1959 | |
| EPO | Filing, Examination, Granting | 8861 | |
| Japan | Filing, Examination, Granting | 2009 | |
| South Korea | Filing, Examination, Granting | 1713 | |
| USA | Filing, Examination, Granting | 8340 |
Total:
22,882
Contact Us
Abstract[English]
A specially prepared herbal tea (1.5 g) for patients with Type II diabetes mellitus is derived from Gymnema lactiferum leaves. This tea was utilized in a randomized, double blind, controlled clinical trial at the Diabetic Center, Teaching Hospital Jaffna, Sri Lanka. In this trial, participants were randomly divided into two groups: one group received one cup of herbal tea per day in addition to their conventional medications, while the other group received one cup of green tea as an active control for three months. Blood samples were analyzed according to the schedule outlined in the mode of intervention, which helped achieve better glycemic control in uncontrolled or poorly controlled diabetes, along with a decrease in total cholesterol, LDL cholesterol, and triglycerides. Blood pressure was reduced in patients with elevated blood pressure, and body weight decreased, with no significant reduction in HDL cholesterol among Type II diabetes mellitus patients.[French]
Tisane spécialement préparée (1,5 g) pour des patients atteints de diabète sucré de type II qui est dérivée de feuilles du Gymnema lactiferum. Cette tisane a été utilisée dans un essai clinique contrôlé randomisé, à double insu, au centre diabétique de l'hôpital universitaire de Jaffna, au Sri Lanka. Dans cet essai, les participants ont été divisés de manière aléatoire en deux groupes : un groupe a reçu une tasse de tisane par jour en plus de leurs médicaments classiques, tandis que l'autre groupe a reçu une tasse de thé vert en tant que contrôle actif pendant trois mois. Des échantillons de sang ont été analysés selon le programme décrit dans le mode d'intervention, ce qui a permis d'obtenir un meilleur contrôle glycémique dans le diabète non contrôlé ou mal contrôlé, conjointement avec une diminution du cholestérol total, du cholestérol LDL et des triglycérides. La pression artérielle a été réduite chez des patients ayant une pression artérielle élevée, et le poids corporel a diminué, sans réduction considérable du cholestérol HDL parmi les patients atteints de diabète sucré de type II.